Mercè Boada, leader of the MOPEAD project, shares her experiences of COVID-19 lockdown
During the lockdown, I am distancing myself socially whilst continuing my work for Fundació ACE.
MOPEAD
Alzheimer Europe Lunch Debate focusses on improving the diagnosis of dementia
On 10 December, two Innovative Medicines Initiative projects participated in an Alzheimer Europe Lunch Debate.
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
The MOPEAD project gathered for closing meeting in Cologne
On 1 to 2 October, the MOPEAD closing meeting took place in Cologne. The main
Interim Analysis of MOPEAD Project presented at AAIC 2019
Cambridge Cognition presented an interim analysis of the MOPEAD Projects patient engagement model at the Alzheimer’s Association International Conference.
Neuronet Scientific Coordination Board meeting brings together project leaders
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.